Cargando…

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year

BACKGROUND: Mifepristone for medical abortion was first dispensed by community pharmacists in Canada directly to patients in January 2017. We asked about pharmacists’ experiences over their first year dispensing mifepristone in order to evaluate the frequency of the new practice and assess availabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zusman, Enav Z., Munro, Sarah, Norman, Wendy V., Soon, Judith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Research and Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331362/ https://www.ncbi.nlm.nih.gov/pubmed/37435503 http://dx.doi.org/10.1177/17151635231176270

Ejemplares similares

Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022)

Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing
por: Rebic, Nevena, et al.
Publicado: (2021)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation
por: Munro, Sarah, et al.
Publicado: (2021)

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
por: Devane, Courtney, et al.
Publicado: (2019)

Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol
por: Norman, Wendy V, et al.
Publicado: (2019)

Leadership for success in transforming medical abortion policy in Canada
por: Dineley, Brigid, et al.
Publicado: (2020)

The Perspective of Rural Physicians Providing Abortion in Canada: Qualitative Findings of the BC Abortion Providers Survey (BCAPS)
por: Dressler, Jennifer, et al.
Publicado: (2013)

Barriers to Rural Induced Abortion Services in Canada: Findings of the British Columbia Abortion Providers Survey (BCAPS)
por: Norman, Wendy V., et al.
Publicado: (2013)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

First trimester medication abortion practice in the United States and Canada
por: Jones, Heidi E., et al.
Publicado: (2017)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative study
por: Carson, Andrea, et al.
Publicado: (2023)

Telemedicine for First-Trimester Medical Abortion in Canada: Results of a 2019 Survey
por: Renner, Regina M., et al.
Publicado: (2023)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Women Pharmacists and Hospital Dispensing
por: Udale, Geo. W.
Publicado: (1912)

Public Pharmacists' and Dispensers' Association
Publicado: (1913)

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017()
por: Jones, Rachel K.
Publicado: (2020)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
por: Wang, Kai, et al.
Publicado: (2022)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Successful conservative management with methotrexate and mifepristone of cervical pregnancy
por: Shrestha, Eliza, et al.
Publicado: (2011)

A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study
por: Dunn, Sheila, et al.
Publicado: (2022)

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022)

Cost-effectiveness of pharmacist care for managing hypertension in Canada
por: Marra, Carlo, et al.
Publicado: (2017)

Exploring the impact of mifepristone’s risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics()
por: Razon, Na’amah, et al.
Publicado: (2022)

Enhancing access to contraception through pharmacist prescribing across Canada
por: Soon, Judith A., et al.
Publicado: (2021)

Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa
por: Constant, Deborah, et al.
Publicado: (2016)

Should Medical Practitioners Dispense?: II. The Pharmacists Point of View
Publicado: (1910)

Dr. Ellwood on Medical Gardening: Public Pharmacists' and Dispensers' Association
Publicado: (1914)

Dispensing practices for psychotropic medications amongst pharmacists in Karachi, Pakistan
por: Hasan, Shahzain, et al.
Publicado: (2022)

Nurse practitioners on ‘the leading edge’ of medication abortion care: A feminist qualitative approach
por: Carson, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sf6fj8cbspl59s7kr5pf1qthm7